{
    "clinical_study": {
        "@rank": "48668", 
        "arm_group": [
            {
                "arm_group_label": "Hyaluronic acid", 
                "arm_group_type": "Experimental", 
                "description": "220 mg hyaluronic acid per tablet (two tablets/day for 10 days, and subsequently one tablet/day for three months)"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "two tablets/day for 10 days, and subsequently one tablet/day for three months"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the effectiveness of low molecular weight hyaluronic acid oral tablets for the\n      treatment of atrophic vaginitis."
        }, 
        "brief_title": "Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis", 
        "condition": "Atrophic Vaginitis", 
        "condition_browse": {
            "mesh_term": [
                "Vaginitis", 
                "Atrophy"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  at least 12 months postmenopausal\n\n          -  mucosal atrophy and the main bothersome related symptoms, such as itching, burning,\n             and dyspareunia."
            }, 
            "gender": "Female", 
            "maximum_age": "65 Years", 
            "minimum_age": "45 Years"
        }, 
        "firstreceived_date": "December 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02014428", 
            "org_study_id": "HA-123"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hyaluronic acid", 
                "intervention_name": "Hyaluronic acid", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hyaluronic Acid"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Messina", 
                    "country": "Italy"
                }, 
                "name": "Department of Gynecological, Obstetric Sciences and Reproductive Medicine, University of Messina."
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Morphometric analysis of biopsies.", 
            "measure": "Atrophic vaginal changes", 
            "time_frame": "Change from baseline epithelium at 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02014428"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Scale: absent, mild, moderate, severe.", 
                "measure": "Assessment of Itching", 
                "time_frame": "Change from baseline Itching at 3 months"
            }, 
            {
                "description": "Scale: absent, mild, moderate, severe.", 
                "measure": "Assessment of Burning", 
                "time_frame": "Change from baseline Burning at 3 months"
            }, 
            {
                "description": "Scale: absent, mild, moderate, severe.", 
                "measure": "Assessment of Dyspareunia", 
                "time_frame": "Change from baseline Dyspareunia at 3 months"
            }
        ], 
        "source": "AGUNCO Obstetrics and Gynecology Centre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AGUNCO Obstetrics and Gynecology Centre", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}